Editorial
doi: 10.1056/NEJMe1007445.
Epub 2010 Jul 7.
Don't mess with the DSMB
- PMID: 20647188
- DOI: 10.1056/NEJMe1007445
Item in Clipboard
Editorial
Don't mess with the DSMB
N Engl J Med.
.
Free article
No abstract available
Comment in
-
More on DSMBs.N Engl J Med. 2011 May 12;364(19):1879-80. doi: 10.1056/NEJMc1102867. N Engl J Med. 2011. PMID: 21561365 No abstract available.
Comment on
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21. N Engl J Med. 2007. PMID: 17517853
-
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.N Engl J Med. 2007 Jul 5;357(1):28-38. doi: 10.1056/NEJMoa073394. Epub 2007 Jun 5. N Engl J Med. 2007. PMID: 17551159 Clinical Trial.
-
Analyses of cancer data from three ezetimibe trials.N Engl J Med. 2008 Sep 25;359(13):1357-66. doi: 10.1056/NEJMsa0806603. Epub 2008 Sep 2. N Engl J Med. 2008. PMID: 18765432
-
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2. N Engl J Med. 2008. PMID: 18765433 Clinical Trial.
-
Premature release of data from clinical trials of ezetimibe.N Engl J Med. 2009 Aug 13;361(7):712-7. doi: 10.1056/NEJMsr0900910. N Engl J Med. 2009. PMID: 19675335 No abstract available.
Similar articles
-
Ezetimibe and cancer--an uncertain association.N Engl J Med. 2008 Sep 25;359(13):1398-9. doi: 10.1056/NEJMe0807200. Epub 2008 Sep 2. N Engl J Med. 2008. PMID: 18765434 No abstract available.
-
Identifying and addressing safety signals in clinical trials.N Engl J Med. 2008 Sep 25;359(13):1400-2. doi: 10.1056/NEJMe0807372. Epub 2008 Sep 3. N Engl J Med. 2008. PMID: 18768938 Free PMC article. No abstract available.
-
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.N Engl J Med. 2008 Sep 25;359(13):1343-56. doi: 10.1056/NEJMoa0804602. Epub 2008 Sep 2. N Engl J Med. 2008. PMID: 18765433 Clinical Trial.
-
Ezetimibe/simvastatin.Expert Opin Drug Saf. 2009 Nov;8(6):715-25. doi: 10.1517/14740330903282745. Expert Opin Drug Saf. 2009. PMID: 19968571 Review.
-
Ezetimibe + simvastatin (Merck/Schering-Plough).Curr Opin Investig Drugs. 2004 Sep;5(9):984-92. Curr Opin Investig Drugs. 2004. PMID: 15503655 Review.
Cited by
-
Impact of data transparency: Scientific publications.Perspect Clin Res. 2018 Jan-Mar;9(1):31-36. doi: 10.4103/picr.PICR_104_17. Perspect Clin Res. 2018. PMID: 29430415 Free PMC article. Review.
-
A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting.Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):9-16. doi: 10.1002/pds.5172. Epub 2020 Nov 24. Pharmacoepidemiol Drug Saf. 2021. PMID: 33179845 Free PMC article.
-
Addressing risks to advance mental health research.JAMA Psychiatry. 2013 Dec;70(12):1363-71. doi: 10.1001/jamapsychiatry.2013.2105. JAMA Psychiatry. 2013. PMID: 24173618 Free PMC article.
-
Corporate practices and health: a framework and mechanisms.Global Health. 2018 Feb 15;14(1):21. doi: 10.1186/s12992-018-0336-y. Global Health. 2018. PMID: 29448968 Free PMC article. Review.
-
Data monitoring committees: Promoting best practices to address emerging challenges.Clin Trials. 2017 Apr;14(2):115-123. doi: 10.1177/1740774516688915. Epub 2017 Feb 1. Clin Trials. 2017. PMID: 28359194 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
